Liquidia Corporation Stock Analysis & AI Score
Liquidia Corporation (LQDA) has an ST Score of 54.1 (B-), driven by its Profitability (A+) and held back by its Valuation (F). Analysts rate it Buy with a $98.11 price target (+38.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Liquidia Corporation (LQDA) has an ST Score of 54.1 (B-), driven by its Profitability (A+) and held back by its Valuation (F). Analysts rate it Buy with a $98.11 price target (+38.3% upside).
- Strongest
- ProfitabilityA+
- Weakest
- ValuationF
All factor grades
- ProfitabilityA+
- MomentumB
- GrowthB
- ForecastB
- Financial StrengthD+
- ValuationF
- Piotroski6/9
Contact
LQDA stock: frequently asked questions
What is LQDA's ST Score?
Liquidia Corporation (LQDA) has an ST Score of 54.1 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is LQDA a buy, hold, or sell?
Analysts rate LQDA a Buy, with a price target of $98.11 (+38.3% vs the current price). Our ST Score grades it B- (54.1/100). The ST Score is a data-driven signal, not a recommendation.
What are LQDA's factor grades?
Valuation F, Profitability A+, Financial Strength D+, Momentum B, Growth B, Forecast B.
What is LQDA's valuation grade?
Liquidia Corporation (LQDA) earns a valuation grade of F, measured against Medical - Pharmaceuticals peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is LQDA's growth grade?
Liquidia Corporation (LQDA) earns a growth grade of B, measured against Medical - Pharmaceuticals peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is LQDA's profitability grade?
Liquidia Corporation (LQDA) earns a profitability grade of A+, measured against Medical - Pharmaceuticals peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is LQDA's financial strength grade?
Liquidia Corporation (LQDA) earns a financial strength grade of D+, measured against Medical - Pharmaceuticals peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for LQDA?
The average analyst price target for Liquidia Corporation (LQDA) is $98.11 from 7 analysts, which is +38.3% versus the recent price of $70.95.
What is LQDA's Piotroski score?
Liquidia Corporation (LQDA) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.